HomeEPIX • NASDAQ
ESSA Pharma Inc
add
Market news
.INX
0.83%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.38M | -29.65% |
Net income | -6.37M | 29.09% |
Net profit margin | — | — |
Earnings per share | -0.19 | 28.71% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 113.87M | -16.20% |
Total assets | 115.42M | -16.30% |
Total liabilities | 1.87M | -57.79% |
Total equity | 113.55M | — |
Shares outstanding | 44.39M | — |
Price to book | 0.66 | — |
Return on assets | -15.50% | — |
Return on capital | -15.85% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -6.37M | 29.09% |
Cash from operations | -6.85M | -0.45% |
Cash from investing | -153.89K | -100.25% |
Cash from financing | — | — |
Net change in cash | -7.00M | -112.43% |
Free cash flow | -5.13M | -16.11% |
Previous close
$1.70
Day range
$1.69 - $1.74
Year range
$1.40 - $7.88
Market cap
77.24M USD
Avg Volume
75.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Headquarters
Website
Employees
35